These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

961 related items for PubMed ID: 28686452

  • 1. Immunostimulatory Properties of Lipid Modified CpG Oligonucleotides.
    Yu C, An M, Li M, Liu H.
    Mol Pharm; 2017 Aug 07; 14(8):2815-2823. PubMed ID: 28686452
    [Abstract] [Full Text] [Related]

  • 2. Three CpG oligodeoxynucleotide classes differentially enhance antigen-specific humoral and cellular immune responses in mice.
    Liu Y, Luo X, Yang C, Yu S, Xu H.
    Vaccine; 2011 Aug 05; 29(34):5778-84. PubMed ID: 21664398
    [Abstract] [Full Text] [Related]

  • 3. Conjugation of lipid and CpG-containing oligonucleotide yields an efficient method for liposome incorporation.
    Andrews CD, Provoda CJ, Ott G, Lee KD.
    Bioconjug Chem; 2011 Jul 20; 22(7):1279-86. PubMed ID: 21612239
    [Abstract] [Full Text] [Related]

  • 4. Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21.
    Lai CY, Yu GY, Luo Y, Xiang R, Chuang TH.
    Front Immunol; 2019 Jul 20; 10():179. PubMed ID: 30800129
    [Abstract] [Full Text] [Related]

  • 5. Carbonate Apatite Nanoparticles Act as Potent Vaccine Adjuvant Delivery Vehicles by Enhancing Cytokine Production Induced by Encapsulated Cytosine-Phosphate-Guanine Oligodeoxynucleotides.
    Takahashi H, Misato K, Aoshi T, Yamamoto Y, Kubota Y, Wu X, Kuroda E, Ishii KJ, Yamamoto H, Yoshioka Y.
    Front Immunol; 2018 Jul 20; 9():783. PubMed ID: 29720976
    [Abstract] [Full Text] [Related]

  • 6. CpG ODN mimicking CpG rich region of myxosporean Myxobolus supamattayai stimulates innate immunity in Asian sea bass (Lates calcarifer) and defense against Streptococcus iniae.
    U-Taynapun K, Chirapongsatonkul N, Itami T, Tantikitti C.
    Fish Shellfish Immunol; 2016 Nov 20; 58():116-124. PubMed ID: 27629917
    [Abstract] [Full Text] [Related]

  • 7. Targeting Suppressive Oligonucleotide to Lymph Nodes Inhibits Toll-like Receptor-9-Mediated Activation of Adaptive Immunity.
    Yu C, An M, Jones E, Liu H.
    Pharm Res; 2018 Feb 08; 35(3):56. PubMed ID: 29423660
    [Abstract] [Full Text] [Related]

  • 8. Lipid Nanoparticle Delivery Alters the Adjuvanticity of the TLR9 Agonist CpG by Innate Immune Activation in Lymphoid Tissue.
    Zhong Z, Chen Y, Deswarte K, Lauwers H, De Lombaerde E, Cui X, Van Herck S, Ye T, Gontsarik M, Lienenklaus S, Sanders NN, Lambrecht BN, De Koker S, De Geest BG.
    Adv Healthc Mater; 2023 Dec 08; 12(32):e2301687. PubMed ID: 37772637
    [Abstract] [Full Text] [Related]

  • 9. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
    Tada R, Muto S, Iwata T, Hidaka A, Kiyono H, Kunisawa J, Aramaki Y.
    BMC Res Notes; 2017 Jan 26; 10(1):68. PubMed ID: 28126014
    [Abstract] [Full Text] [Related]

  • 10. S-540956, a CpG Oligonucleotide Annealed to a Complementary Strand With an Amphiphilic Chain Unit, Acts as a Potent Cancer Vaccine Adjuvant by Targeting Draining Lymph Nodes.
    Nakagawa T, Tanino T, Onishi M, Tofukuji S, Kanazawa T, Ishioka Y, Itoh T, Kugimiya A, Katayama K, Yamamoto T, Nagira M, Ishii KJ.
    Front Immunol; 2021 Jan 26; 12():803090. PubMed ID: 35003132
    [Abstract] [Full Text] [Related]

  • 11. Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system.
    Hanagata N.
    Int J Nanomedicine; 2012 Jan 26; 7():2181-95. PubMed ID: 22619554
    [Abstract] [Full Text] [Related]

  • 12. Single Stranded DNA Immune Modulators with Unmethylated CpG Motifs: Structure and Molecular Recognition by Toll-Like Receptor 9.
    Fehér K.
    Curr Protein Pept Sci; 2019 Jan 26; 20(11):1060-1068. PubMed ID: 31470785
    [Abstract] [Full Text] [Related]

  • 13. Lipid Nanoparticles Potentiate CpG-Oligodeoxynucleotide-Based Vaccine for Influenza Virus.
    Shirai S, Shibuya M, Kawai A, Tamiya S, Munakata L, Omata D, Suzuki R, Aoshi T, Yoshioka Y.
    Front Immunol; 2019 Jan 26; 10():3018. PubMed ID: 31998305
    [Abstract] [Full Text] [Related]

  • 14. Cytosine-phosphate-guanine oligodeoxynucleotides containing GACGTT motifs enhance the immune responses elicited by keyhole limpet hemocyanin antigen in dairy cattle.
    Chu CY, Lee SC, Liu SS, Lin YM, Shen PC, Yu C, Lee KH, Zhao X, Lee JW.
    Nucleic Acid Ther; 2011 Oct 26; 21(5):323-32. PubMed ID: 21916610
    [Abstract] [Full Text] [Related]

  • 15. Double-stranded phosphodiester cytosine-guanine oligodeoxynucleotide complexed with calcium phosphate as a potent vaccine adjuvant for activating cellular and Th1-type humoral immunities.
    Hanagata N, Li X, Chen MH, Li J, Hattori S.
    Int J Nanomedicine; 2018 Oct 26; 13():43-62. PubMed ID: 29317815
    [Abstract] [Full Text] [Related]

  • 16. G3139 and other CpG-containing immunostimulatory phosphorothioate oligodeoxynucleotides are potent suppressors of the growth of human tumor xenografts in nude mice.
    Gekeler V, Gimmnich P, Hofmann HP, Grebe C, Römmele M, Leja A, Baudler M, Benimetskaya L, Gonser B, Pieles U, Maier T, Wagner T, Sanders K, Beck JF, Hanauer G, Stein CA.
    Oligonucleotides; 2006 Oct 26; 16(1):83-93. PubMed ID: 16584297
    [Abstract] [Full Text] [Related]

  • 17. Synthetic methylated CpG ODNs are potent in vivo adjuvants when delivered in liposomal nanoparticles.
    Chikh G, de Jong SD, Sekirov L, Raney SG, Kazem M, Wilson KD, Cullis PR, Dutz JP, Tam YK.
    Int Immunol; 2009 Jul 26; 21(7):757-67. PubMed ID: 19502586
    [Abstract] [Full Text] [Related]

  • 18. Class-B CpG-ODN Formulated With a Nanostructure Induces Type I Interferons-Dependent and CD4+ T Cell-Independent CD8+ T-Cell Response Against Unconjugated Protein Antigen.
    Chiodetti AL, Sánchez Vallecillo MF, Dolina JS, Crespo MI, Marin C, Schoenberger SP, Allemandi DA, Palma SD, Pistoresi-Palencia MC, Morón G, Maletto BA.
    Front Immunol; 2018 Jul 26; 9():2319. PubMed ID: 30364187
    [Abstract] [Full Text] [Related]

  • 19. Immunization with antigenic peptides complexed with β-glucan induces potent cytotoxic T-lymphocyte activity in combination with CpG-ODNs.
    Mochizuki S, Morishita H, Kobiyama K, Aoshi T, Ishii KJ, Sakurai K.
    J Control Release; 2015 Dec 28; 220(Pt A):495-502. PubMed ID: 26562685
    [Abstract] [Full Text] [Related]

  • 20. Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN.
    de Jong S, Chikh G, Sekirov L, Raney S, Semple S, Klimuk S, Yuan N, Hope M, Cullis P, Tam Y.
    Cancer Immunol Immunother; 2007 Aug 28; 56(8):1251-64. PubMed ID: 17242927
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.